Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

hereditary spastic paraplegia News | Kisho

Kisho

Not rare diseases news,
news about your rare disease.

Earlier

A case report details two siblings with spastic paraplegia and psychomotor retardation linked to HACE1 gene variants. This study contributes to the understanding of genetic factors in rare neurological disorders.

A new study details the clinical characteristics of KCNA2-associated hereditary spastic paraplegia, highlighting the need for targeted treatment approaches. This research contributes to understanding the disease's genetic underpinnings and potential therapeutic strategies.

A retrospective cohort study examines rehabilitation management strategies for children with hereditary spastic paraplegia. The findings contribute to understanding effective interventions for this rare condition.

A new cellular imaging-based method shows promise as a potential biomarker for SPG4 hereditary spastic paraplegia. This discovery could enhance diagnostic accuracy and monitoring for this rare genetic condition.

A recent study published in PubMed explores the clinical, genetic, and neuroimaging features of SPG46, a rare hereditary spastic paraplegia. The findings contribute to understanding the disease's pathophysiology and may inform future research directions.

A recent study published in PubMed highlights the presence of FTLD-TDP-43 pathology in a patient with spastic paraplegia-30B linked to a homozygous KIF1A variant. This research contributes to the understanding of the genetic underpinnings of motor neuron disease.

A cohort study involving 103 families enhances the understanding of the genetic and clinical aspects of hereditary spastic paraplegia (HSP). This research could inform future therapeutic strategies and genetic counseling for affected families.

A recent study elucidates genotype-structure-phenotype correlations in early-onset spastic paraplegia type 4, highlighting its divergent natural history. This research contributes to understanding the disease's variability and may inform future therapeutic strategies.

A new prospective study explores the impact of diet and metabolism on patients with hereditary spastic paraplegia. This research could provide insights into managing the disease beyond mobility issues.

Not rare diseases news,news about your rare disease.